Navigation Links
Leading Rehab Facility Urges Patients Not to Stop Taking Antidepressants After New Study Suggests Increased Risk of Heart Attacks and Strokes

MALIBU, Calif., April 6, 2011 /PRNewswire/ -- Cliffside Malibu, one of America's leading drug and alcohol treatment centers, is strongly urging its patients who are currently taking antidepressants not to stop, despite a new study and subsequent media reports that such drugs could raise the risk of heart attack or stroke in middle-age men taking the medications.  Cliffside is using e-mail, phone calls and face-to-face therapy sessions to encourage its patients who rely on those medications to continue doing so under close supervision by their psychiatrists.

"While the findings of this very preliminary study are interesting and should be taken seriously, we are strongly urging our patients to continue using antidepressants as prescribed," said Cliffside Malibu CEO Richard Taite.  "The immediate, serious risks to our patients were they to abruptly halt the use of antidepressants far outweigh potential adverse health effects."

A presentation at a cardiology conference earlier this week suggested antidepressants could lead to as much as a five percent increase in the thickness of the carotid artery.  The study's author, Dr. Amit Shah, has reportedly cautioned that the findings of the 513-person study are not enough to warrant taking patients off of antidepressants, and noted that depression elevates risk for heart disease.

"The symptoms of depression in our patients, many of whom suffer from mood and other disorders, are often acute and even life-threatening.  We are reaching out to every current and former patient to educate them and to ensure they make wise decisions in partnership with their physicians," added Taite.

About Cliffside Malibu

Cliffside Malibu is a full-service residential drug rehab and alcohol addiction treatment center in the Los Angeles area.  At Cliffside, highly trained experts administer individually tailored addiction rehabilitation programs for patients who place a premium on privacy, safety, and, most importantly, effectiveness.  The drug rehabilitation facility gets its name from its striking location, perched on a cliff overlooking the Pacific Ocean.  For more information, visit or call 800-501-1988.  

SOURCE Cliffside Malibu
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Leading Anti-Cancer Drugs: World Market Prospects 2011-2021
2. Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium
3. Newtech, Inc., a Leading Chinese EMS Patient Monitoring Company, Partners With Masimo to Incorporate rainbow® SET Noninvasive Measurement Capabilities Into New Patient Monitors
4. Leading Hospitals Committed to Healthcares Adoption of GS1 Standards Use Omnicell Solutions for Supply Chain Management
5. Life Technologies Initiates Clinical Trials Leading to 510(k) Submission of a Class I and Class II HLA Sequence-Based Typing Solution
6. Quest Diagnostics to Acquire Celera, Strengthening Position as Worlds Leading Innovator in Molecular Diagnostics and Development
7. First Varian High Dose Rate Brachytherapy Afterloader Supplied to Leading China Cancer Hospital
8. Two National Organizations Join DRIVE4COPD Movement to Raise Awareness of Nations Fourth Leading Cause of Death
9. PDI Announces Exclusive Partnership With Qforma, Leading Provider of Advanced Analytics for Health Sciences Industry
10. DJO Global to Acquire Leading Therapeutic Footwear Provider, Dr. Comfort
11. Reportlinker Adds The 2011 Top Ten Worlds Leading Pharmaceutical Companies
Post Your Comments:
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 27, 2016 , ... TherapySites, the leading website ... Tennessee Counseling Association. This new relationship allows TherapySites to continue to ... adding exclusive benefits and promotional offers. , "TCA is extremely excited about this ...
(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
Breaking Medicine News(10 mins):